The potential use of mesenchymal stem cells and their derived exosomes as immunomodulatory agents for COVID‐19 patients
A novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing lethal acute
respiratory disease emerged in December 2019. The World Health Organization named this …
respiratory disease emerged in December 2019. The World Health Organization named this …
Therapeutic potential of mesenchymal stem cells and their products in lung diseases—intravenous administration versus inhalation
E Fröhlich - Pharmaceutics, 2021 - mdpi.com
The number of publications studying the therapeutic use of stem cells has steadily increased
since 2000. Compared to other applications, there has been little interest in the evaluation of …
since 2000. Compared to other applications, there has been little interest in the evaluation of …
[HTML][HTML] Cellular therapy: the hope for covid-19
S Nobari, M Rezvan, F Dashtestani… - Avicenna Journal of …, 2022 - ncbi.nlm.nih.gov
Coronaviruses (CoVs) are a group of very diverse viruses that cause a broad spectrum of
diseases from mild to severe enteric, respiratory, systemic diseases, and common cold or …
diseases from mild to severe enteric, respiratory, systemic diseases, and common cold or …
Stem Cell Delivery Systems and Devices-Spraying
SY Kim, W Chrzanowski - Stem Cell-Based Therapy for Lung Disease, 2019 - Springer
Despite huge progress in interrogating the benefits of stem cells for lung diseases, more
studies on optimal routes of cell delivery are required. The ability of intravenously injected …
studies on optimal routes of cell delivery are required. The ability of intravenously injected …
Significance of exosomes in covid-19 pathogenesis and therapy
P Basiri, MH Soheilifar, AH Nikfarjam, HK Neghab… - Koomesh, 2021 - brieflands.com
: Exosomes are lipid bilayer-enclosed nano-sized vesicles, which carry various
biomolecules including proteins, lipids, and microRNAs. SARS-CoV-2-loaded exosomes …
biomolecules including proteins, lipids, and microRNAs. SARS-CoV-2-loaded exosomes …
[HTML][HTML] Best of Milan 2017—Repair of the emphysematous lung: Mesenchymal stromal cell and matrix
F Polverino - Journal of Thoracic Disease, 2017 - ncbi.nlm.nih.gov
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017; 9 (Suppl 16): S1544-
S1547 jtd. amegroups. com from different sources were compared, even when cells have …
S1547 jtd. amegroups. com from different sources were compared, even when cells have …
[PDF][PDF] Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation. Pharmaceutics. 2021 …
E Fröhlich - 2021 - pdfs.semanticscholar.org
The number of publications studying the therapeutic use of stem cells has steadily increased
since 2000. Compared to other applications, there has been little interest in the evaluation of …
since 2000. Compared to other applications, there has been little interest in the evaluation of …
[PDF][PDF] Stem Cell-Based Therapy for Lung
JK Burgess, IH Heijink - drive.google.com
Nevertheless, the field of stem cells and their mechanisms in lung pathologies is complex,
and the challenge of realizing the clinical potential of stem cell-based regenerative medicine …
and the challenge of realizing the clinical potential of stem cell-based regenerative medicine …